Multiple sclerosis and human herpesvirus 6

Infection

Volumn 30, Issue 3, 2002, Pages 145-149

  Gutierrez J ^a   Vergara, M J ^a   Guerrero, M ^a   Fernandez O ^b   Piedrola G ^a   Morales, P ^a   Del C Maroto, M ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b University Hospital Carlos Haya   (Spain)

Author keywords

CMV; EBV; Herpesvirus; HHV 6; Multiple sclerosis

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; VIRUS DNA; VIRUS ANTIBODY; VIRUS RNA;

ADULT; ANTIBODY SPECIFICITY; ARTICLE; CEREBROSPINAL FLUID EXAMINATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; DEMYELINATING DISEASE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; FEMALE; HERPES SIMPLEX VIRUS; HUMAN; HUMAN HERPESVIRUS 6; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NONHUMAN; POLYMERASE CHAIN REACTION; SEROLOGY; SERUM; VIRUS DETECTION; VIRUS INFECTION; BLOOD; CASE CONTROL STUDY; CEREBROSPINAL FLUID; COMORBIDITY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; EPIDEMIOLOGY; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED; NONPARAMETRIC TEST; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SPAIN;

ADULT; ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; COMORBIDITY; COMPARATIVE STUDY; CONFIDENCE INTERVALS; CYTOMEGALOVIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPESVIRUS 4, HUMAN; HERPESVIRUS 6, HUMAN; HUMAN; MALE; MIDDLE AGE; MULTIPLE SCLEROSIS; REFERENCE VALUES; RNA, VIRAL; ROSEOLOVIRUS INFECTIONS; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; SPAIN; STATISTICS, NONPARAMETRIC; SUPPORT, NON-U.S. GOV'T; HUMANS; MIDDLE AGED;

EID: 0035989984     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-002-2056-7     Document Type: Article

References (35)

1. Human herpesvirus 6
2. Epidemiologic evidence for multiple sclerosis as an infection
3. The pathogenesis of multiple sclerosis: Reconsideration of the role of viral agents and defence mechanisms
4. The virology of demyelinating diseases
5. Detection of human herpesvirus 6 variant A in peripheral blood mononuclear cells from multiple sclerosis patients
6. Human herpesvirus 6 and multiple sclerosis: Systemic active infections in patients with early disease
7. Latent herpesvirus 6 infection of human monocytes/macrophages
8. Factores genéticos y medioambientales en esclerosis múltiple
9. Epstein-Barr virus and oral squamous cell carcinoma in patients without HIV infection: Viral detection by polymerase chain reaction
10. Amplification of the six major human herpesviruses from cerebrospinal fluid by a single PCR
11. Avoiding false positives with PCR
12. Reliability of low-avidity IgG and of IgA in the diagnosis of primary infection by rubella virus with adaptation of a commercial test
13. Evaluation of a commercial enzyme-linked immunosorbent assay for detection of serum immunoglobulin G response to human herpesvirus 6
14. Evaluation of a new reagent for anti-cytomegalovirus and Epstein-Barr virus IgG
15. Behaviour of IgG antibody avidity for the antigen and of IgA in active cytomegalovirus, Epstein-Barr virus, herpes simplex virus and human herpes virus-6 infections. Adaptation of a commercial test
16. Human herpesvirus 6 and multiple sclerosis: Survey of anti-HHV-6 antibodies by immunofluorescence analysis and of viral sequences by polymerase chain reaction
17. Human herpesvirus-6 immunoglobulin G antibodies in patients with multiple sclerosis
18. Association of human herpesvirus 6 (HHV-6) with multiple sclerosis: Increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA
19. The association of the human herpesvirus-6 and MS
20. A pilot study on the antibodies to HHV-6 variants and HHV-7 in CSF of MS patients
21. Human herpesvirus-6 (HHV-6) infection in multiple sclerosis: A preliminary report
22. Absence of seven human herpesviruses, including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis
23. Determinación de genomas de virus de la familia Herpesviridae en enfermos de esclerosis múltiple, por la reacción en cadena de la polimerasa (PCR)
24. Polymerase chain reaction analysis of human herpesvirus-6 sequences in the sera and cerebrospinal fluid of patients with multiple sclerosis
25. Similar humoral and cellular immunological reactivities to human herpesvirus 6 in patients with multiple sclerosis and controls
26. A potential role for human herpesvirus type 6 in nervous system disease
27. Detection of human herpesvirus 6 and human herpesvirus 7 in the submandibular gland, parotid gland, and lip salivary gland by PCR
28. Absence of HHV-6 and HHV-7 in cerebrospinal fluid in relapsing-remitting multiple sclerosis
29. Detection of human herpesvirus 6 DNA in serum by a microplate PCR-hybridization assay
30. Altered antibody pattern to Epstein-Barr virus but not other herpesviruses in multiple sclerosis: A population case-control study from western Norway
31. The significance of Epstein-Barr virus seropositivity in multiple sclerosis patients?
32. Epstein-Barr virus reactivation associated with MS disease activity
33. Intrathecal secretion of antiviral antibodies in multiple sclerosis patients in Seville
34. Epstein-Barr virus nuclear antigen-1 (EBNA-1) associated oligoclonal bands in patients with multiple sclerosis